162 related articles for article (PubMed ID: 31616294)
1. Photobinding of Triflusal to Human Serum Albumin Investigated by Fluorescence, Proteomic Analysis, and Computational Studies.
Molins-Molina O; Pérez-Ruiz R; Lence E; González-Bello C; Miranda MA; Jiménez MC
Front Pharmacol; 2019; 10():1028. PubMed ID: 31616294
[TBL] [Abstract][Full Text] [Related]
2. Photosensitivity to Triflusal: Formation of a Photoadduct with Ubiquitin Demonstrated by Photophysical and Proteomic Techniques.
Nuin E; Pérez-Sala D; Lhiaubet-Vallet V; Andreu I; Miranda MA
Front Pharmacol; 2016; 7():277. PubMed ID: 27621705
[TBL] [Abstract][Full Text] [Related]
3. Photonucleophilic addition of the epsilon-amino group of lysine to a triflusal metabolite as a mechanistic key to photoallergy mediated by the parent drug.
Montanaro S; Lhiaubet-Vallet V; Jiménez MC; Blanca M; Miranda MA
ChemMedChem; 2009 Jul; 4(7):1196-202. PubMed ID: 19462393
[TBL] [Abstract][Full Text] [Related]
4. Photochemistry of 2-hydroxy-4-trifluoromethylbenzoic acid, major metabolite of the photosensitizing platelet antiaggregant drug triflusal.
Boscá F; Cuquerella MC; Marín ML; Miranda MA
Photochem Photobiol; 2001 May; 73(5):463-8. PubMed ID: 11367565
[TBL] [Abstract][Full Text] [Related]
5. Binding of a metabolite of triflusal (2-hydroxy-4-trifluoromethylbenzoic acid) to serum proteins in rat and man.
Mis R; Ramis J; Conte L; Forn J
Eur J Clin Pharmacol; 1992; 42(2):175-9. PubMed ID: 1618249
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
[TBL] [Abstract][Full Text] [Related]
7. In-vitro protein binding interaction between a metabolite of triflusal, 2-hydroxy-4-trifluoromethylbenzoic acid and other drugs.
Mis R; Ramis J; Conte L; Forn J
J Pharm Pharmacol; 1992 Nov; 44(11):935-7. PubMed ID: 1361542
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.
González-Correa JA; Arrebola MM; Ureña IM; Ruiz-Villafranca D; Muñoz-Marín J; Guerrero A; Sánchez de la Cuesta F; De La Cruz JP
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):81-8. PubMed ID: 15602657
[TBL] [Abstract][Full Text] [Related]
9. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.
Bayón Y; Alonso A; Sánchez Crespo M
Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529
[TBL] [Abstract][Full Text] [Related]
10. Platelet antiaggregatory effect of triflusal in human whole blood.
de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
[TBL] [Abstract][Full Text] [Related]
11. Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.
Valle M; Barbanoj MJ; Donner A; Izquierdo I; Herranz U; Klein N; Eichler HG; Müller M; Brunner M
Eur J Clin Pharmacol; 2005 Apr; 61(2):103-11. PubMed ID: 15711832
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography.
Cho HY; Jeong TJ; Lee YB
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):257-64. PubMed ID: 14643505
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of two oral formulations of triflusal capsules in healthy volunteers.
Quetglas EG; Campanero MA; Sádaba B; Escolar M; Azanza JR
Arzneimittelforschung; 2008; 58(6):283-7. PubMed ID: 18677970
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of triflusal and its main metabolite in rats and dogs.
Ramis J; Mis R; Forn J
Eur J Drug Metab Pharmacokinet; 1991; 16(4):261-8. PubMed ID: 1823869
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.
Ramis J; Mis R; Forn J; Torrent J; Gorina E; Jané F
Eur J Drug Metab Pharmacokinet; 1991; 16(4):269-73. PubMed ID: 1823870
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain.
Kim SW; Choi KJ; Park JY; Yoon SH; Lee JK
Neurosci Lett; 2017 Mar; 643():59-64. PubMed ID: 28189746
[TBL] [Abstract][Full Text] [Related]
17. A New Pathway for Protein Haptenation by β-Lactams.
Pérez-Ruíz R; Lence E; Andreu I; Limones-Herrero D; González-Bello C; Miranda MA; Jiménez MC
Chemistry; 2017 Oct; 23(56):13986-13994. PubMed ID: 28791745
[TBL] [Abstract][Full Text] [Related]
18. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.
de la Cruz JP; Pavia J; Bellido I; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):363-7. PubMed ID: 3412046
[TBL] [Abstract][Full Text] [Related]
19. Effect of food on the pharmacokinetics of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in healthy subjects.
Ge J; Ding LK; Yang J; Jia YY; Lu CT; Ding Y; Song Y; Song W; Wen AD
Int J Clin Pharmacol Ther; 2015 Mar; 53(3):272-6. PubMed ID: 25546165
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Study of Triflusal in Elderly Subjects After Single and Repeated Oral Administration.
Ferrari E; Reboldi G; Marenco P; D'Angelo L; Crema F; Ambrosoli L; Poli A; Girardello R; Lowenthal DT
Am J Ther; 1996 Sep; 3(9):630-636. PubMed ID: 11862303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
